S100A8 and myocardial infarction: Multiple studies have shown that S100A8/A9 plays a vital role in the pathogenesis of inflammatory diseases, including sepsis, myocardial infarction (MI), ischemia/reperfusion, cardiac fibrosis and renal fibrosis; targeting S100A8/A9 effectively improves these diseases and adverse outcomes 10-15.